Loading clinical trials...
Loading clinical trials...
An Open-Label, Multi-Center, Single-Arm Study on Effectiveness and Safety of Stereotactic Body Radiotherapy (SBRT) Treating Hepatocellular Carcinoma Patients With CyberKnife
Conditions
Interventions
CyberKnife
Locations
1
China
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, China
Start Date
May 1, 2014
Primary Completion Date
May 1, 2017
Completion Date
December 1, 2017
Last Updated
October 7, 2016
NCT07225114
NCT04618692
NCT00051545
NCT04518852
NCT06271109
NCT02094625
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions